Associated Papers
Structural insights into the nirmatrelvir-resistant SARS-CoV-2 Mpro L50F/E166A/L167F triple mutant-inhibitor-complex reveal strategies for next generation coronaviral inhibitor design.
Fischer C et al.
Rsc Medicinal Chemistry, 2025
SARS-CoV-2 Resistance to Small Molecule Inhibitors.
Lopez UM et al.
Current Clinical Microbiology Reports, 2024
Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance.
Lewandowski EM et al.
Biorxiv : the Preprint Server for Biology, 2024
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease.
Flynn JM et al.
Acs Infectious Diseases, 2023
Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (Mpro) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
Sahoo P et al.
Acs Pharmacology & Translational Science, 2023
Select a paper to view details